Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for...
-
Upload
reginald-hicks -
Category
Documents
-
view
220 -
download
4
Transcript of Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for...
IMMUNIZATION AND VACCINE DEVELOPMENTIVD
Reaching the 2010 Measles Mortality Reduction Goal-can
SEARO get there?
Meeting of the Partners for Measles Advocacy
Washington DC, 23-24 September 2008
Dr. Pem NamgyalRegional Adviser, Vaccine Preventable Diseases
Immunization and Vaccine DevelopmentDepartment of Family and Community Health, SEARO
Immunization and Vaccine Development, FCH |
Regional Strategic Plan 2007-2010
Goal By 2010 reduce the number of estimated measles deaths by
90% in comparison to 2000Specific objectives
• 1st dose measles coverage >90%, nationally and >80% coverage in all districts by 2010
• Provide a second opportunity for measles immunization by 2010 while achieving >90% coverage
• Case based measles surveillance within integrated surveillance systems in countries that completed catch-up campaigns
• Fully investigate all detected/reported measles outbreaks
Immunization and Vaccine Development, FCH |
0
50000
100000
150000
200000
250000
2000 2001 2002 2003 2004 2005 2006 2007
Est
imat
ed d
eath
s
60
61
62
63
64
65
66
67
68
69
70
MC
V1
Co
vera
ge
(%)
Estimated Measles Deaths WHO/UNICEF estimated MCV 1 coverage
41 million people were vaccinated in SIAs in 2007
Sources: Mortality estimate WHO/HQ MCV1 coverage: WHO/UNICEF best estimates
Estimated measles mortality reduced by 26% between 2000 and 2006
Immunization and Vaccine Development, FCH |
Measles 2nd Opportunity through
Routine Immunization
Catch-up Campaigns completed
Measles 2nd Opportunity through
Catch-up Campaigns
Provide MR/MMR vaccine
Bhutan, Maldives and Sri Lanka provided MRFollow up campaigns planned : Nepal (2008), Bangladesh (2010)
116 million people have been vaccinated from 2000-07
Provide Measles Vaccine
Second Opportunity for Measles Immunization, SEAR, 2008
Immunization and Vaccine Development, FCH |
SEAR Measles Lab Network 2008 (July)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO 2005. All rights reserved
NIV Pune
BJM Ahm IoS Kol
Ref lab for genotyping (India)
(18)
(1)
(1)
Immunization and Vaccine Development, FCH |
Cases from Serologically Confirmed Suspected Measles Outbreaks Nepal, 2003-2008 July
Source: Monthly case-based data, Jul 2008
0
200
400
600
800
1000
1200
1400
Jan
Feb
Mar
Apr
May Jun
Jul
Aug Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May Jun
Jul
Aug Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May Jun
Jul
Aug Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May Jun
Jul
Aug Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May Jun
Jul
Aug Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May Jun
Jul
2003 2004 2005 2006 2007 2008
Nu
mb
er o
f ca
ses
Laboratory confirmed measles
Laboratory confirmed rubella
Mixed measles and rubella
Negative for measles and rubella
Phase 3Phase 2
Measles catch-up campaign
Phase 1
Immunization and Vaccine Development, FCH |
Cases from Serologically Confirmed Suspected Measles Outbreaks Bangladesh, 2004-2008 July
Source: Monthly case-based data, Jul 2008
0
1000
2000
3000
4000
5000
6000
7000
Jan
Feb
Mar
Apr
May Jun
Jul
Aug Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May Jun
Jul
Aug Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May Jun
Jul
Aug Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May Jun
Jul
Aug Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May Jun
Jul
2004 2005 2006 2007 2008
Nu
mb
er o
f ca
ses
Laboratory confirmed measles
Laboratory confirmed rubella
Mixed measles & rubella
Measles Catch-up Campaign
Immunization and Vaccine Development, FCH |
Estimated Measles Mortality, India, 2006
94% deathsIn 10 states
~ 150,000 Deaths
Immunization and Vaccine Development, FCH |
Measles: routine coverage and surveillance in India
• Measles routine coverage in India is low, but showing progressive improvement
• Surveillance in general is poor; in six southern states WHO SMO network is supporting the state government to carry out measles surveillance
• Surveillance needs to be established in other states as well, but who is to do it is the current debate
50
52
54
56
58
60
62
64
66
68
Cove
rage
(%)
2003 2004 2005 2006 2007
MCV1 coverage (%), India
Immunization and Vaccine Development, FCH |
Total cases- 678 Total cases- 1044
Total cases-1132
Andhra Pradesh Gujarat
Tamil Nadu
Total cases- 314
Kerala
Total cases-1838
West Bengal
Total cases- 2530
Karnataka
Serologically confirmed measles outbreaks India: cases by age, 2007
Cases from serologically confirmed measles outbreaks
% % %
% % %
* data as on 10th Jul, 2008
Immunization and Vaccine Development, FCH |
India Technical Advisory Group for Measles Control (ITAGM)
• In 2007 GoI formed the India Technical Advisory Group for Measles (ITAGM) comprising national and international experts to guide the government on the future steps for measles mortality reduction in India
• ITAGM held its 1st meeting in September 2007 and put up its recommendations to National Technical Advisory Group on Immunization (NTAGI)
• NTAGI met on 16 June 2008 endorsed ITAGM recommendations
Immunization and Vaccine Development, FCH |
ITAGM – State specific strategies
Group
1st dose coverage with MCV
Strategy
1 Low Improve RIOne-time catch-up SIA targeting children 9m-10 years*Repeat SIAs targeting new birth cohorts based on RI coverage and surveillance data
2 Medium Improve RIOne-time catch-up SIA targeting children 9m-10 years*Repeat SIAs targeting subsequent birth cohorts and/or introduction of a routine 2nd dose
3 High (>90%) Introduce a routine 2nd dose of measles vaccine
*Target age range for SIAs will be adjusted based on age distribution of recent cases
Immunization and Vaccine Development, FCH |
NTAGI Recommendations for Measles control
a) UIP second dose (MR): States with >=80% evaluated MCV1
b) Catch-up measles SIA campaigns (9mo-10 YR): States with <80% evaluated MCV1.
c) For UP, decision on catch-up SIA after consultation with State Government.
d) CFR studies: in selected high burden states.• Draft proposal developed, being reviewed
e) Expansion of measles surveillance will be done in UP and Bihar and other states with high mortality due to measles for SIA planning and having a baseline.
Immunization and Vaccine Development, FCH |
Recommendations of ITAG and regional priorities
• Implementation of NTAGI recommendations on accelerating measles mortality reduction in India.
– Most importantly, the 10 states of India that account for 90% of measles mortality need to conduct measles catch-up SIAs as soon as possible.
• Technical sub-group to develop SEAR regional rubella control policy
and providing more comprehensive guidance on implementation of measles control and surveillance.
• All countries that have completed catch-up campaigns should initiate measles case-based surveillance with laboratory confirmation and fully investigation of all detected/reported outbreaks.
Immunization and Vaccine Development, FCH |
Can SEA Region Make it?
• The answer is Yes if we can get India to accelerate the process
• The problem is neither financial nor technical
• The most influential partners and from the highest level need to emphasize to the highest authorities in India the importance of India’s achievement to the regional and global ability to achieve the goal for measles mortality reduction